IBDEI1SQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32081,1,3,0)
 ;;=3^Cirrhosis of Liver,Oth
 ;;^UTILITY(U,$J,358.3,32081,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,32081,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,32082,0)
 ;;=K74.60^^190^1946^11
 ;;^UTILITY(U,$J,358.3,32082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32082,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,32082,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,32082,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,32083,0)
 ;;=K76.0^^190^1946^12
 ;;^UTILITY(U,$J,358.3,32083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32083,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,32083,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,32083,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,32084,0)
 ;;=K76.89^^190^1946^18
 ;;^UTILITY(U,$J,358.3,32084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32084,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,32084,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,32084,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,32085,0)
 ;;=K71.6^^190^1946^31
 ;;^UTILITY(U,$J,358.3,32085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32085,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,32085,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,32085,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,32086,0)
 ;;=K75.9^^190^1946^17
 ;;^UTILITY(U,$J,358.3,32086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32086,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,32086,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,32086,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,32087,0)
 ;;=K71.0^^190^1946^23
 ;;^UTILITY(U,$J,358.3,32087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32087,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,32087,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,32087,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,32088,0)
 ;;=K71.10^^190^1946^29
 ;;^UTILITY(U,$J,358.3,32088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32088,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,32088,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,32088,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,32089,0)
 ;;=K71.11^^190^1946^30
 ;;^UTILITY(U,$J,358.3,32089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32089,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,32089,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,32089,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,32090,0)
 ;;=K71.2^^190^1946^22
 ;;^UTILITY(U,$J,358.3,32090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32090,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,32090,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,32090,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,32091,0)
 ;;=K71.3^^190^1946^27
 ;;^UTILITY(U,$J,358.3,32091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32091,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,32091,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,32091,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,32092,0)
 ;;=K71.4^^190^1946^26
 ;;^UTILITY(U,$J,358.3,32092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32092,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,32092,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,32092,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,32093,0)
 ;;=K75.81^^190^1946^19
 ;;^UTILITY(U,$J,358.3,32093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32093,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,32093,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,32093,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,32094,0)
 ;;=K75.89^^190^1946^16
